Korean Circ J.  2011 Jun;41(6):334-337. 10.4070/kcj.2011.41.6.334.

Myopericarditis in a Korean Young Male With Systemic Lupus Erythematosus

• Park KT
• Hong KS
• Han SJ
• Yoon DH
• Choi H
• Lee MY
• Ryu MS
• Lee CW

• KMID: 1776192
• DOI: http://doi.org/10.4070/kcj.2011.41.6.334

Abstract

Myocardial involvement with clinical symptoms is a rare manifestation of systemic lupus erythematosus (SLE), despite the relatively high prevalence of myocarditis at autopsies of SLE patients. In this review, we report the case of a 19-year-old male SLE patient who initially presented with myopericarditis and was successfully treated with high dose of glucocorticoids.

Keyword

Male; Pericarditis; Myocarditis; Systemic lupus erythematosus

MeSH Terms

Autopsy
Glucocorticoids
Humans
Lupus Erythematosus, Systemic
Male
Myocarditis
Pericarditis
Prevalence
Young Adult
Glucocorticoids

Figure

• 

  Fig. 1 Chest X-ray. A: chest X-ray shows patchy consolidation with multiple nodular densities in both the lower lung fields and cardiomegaly. B: chest X-ray following treatment with steroids shows improving consolidation and cardiomegaly.

• 

  Fig. 2 Electrocardiogram and Echocardiogram. A: electorcardiogram (ECG) shows sinus tachycardia and diffuse T-wave inversion in which leads on the day of admission. B: parasternal short axis view shows pericardial effusion and decreased left ventricular ejection fraction. C: ECG shows normal sinus rhythm and left ventricular hypertrophy after glucocorticoid treatment. D: parasternal short axis views show improving left ventricular ejection fraction and decreasing pericardial effusion after glucocorticoid treatment.

Reference

1. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus (SLE). Arthritis Rheum. 1982. 25:1271–1277.

2. Chakravarty EF, Bush TM, Manzi S, Clarke AE, Ward MM. Prevalence of adult systemic lupus erythematosus in California and Pennsylvania in 2000: estimates obtained using hospitalization data. Arthritis Rheum. 2007. 56:2092–2094.

3. Lahita RG. The role of sex hormones in systemic lupus erythematosus. Curr Opin Rheumatol. 1999. 11:352–356.

4. Wijetunga M, Rockson S. Myocarditis in systemic lupus erythematosus. Am J Med. 2002. 113:419–423.

5. Doria A, Iaccarino L, Sarzi-Puttini P, Atzeni F, Turriel M, Petri M. Cardiac involvement in systemic lupus erythematosus. Lupus. 2005. 14:683–686.

6. Bidani AK, Roberts JL, Schwartz MM, Lewis EJ. Immunopathology of cardiac lesions in fatal systemic lupus erythematosus. Am J Med. 1980. 69:849–858.

7. Mandell BF. Cardiovascular involvement in systemic lupus erythematosus. Semin Arthritis Rheum. 1987. 17:126–141.

8. Moder KG, Miller TD, Tazellar HD. Cardiac involvement in systemic lupus erythematosus. Mayo Clin Proc. 1999. 74:275–284.

9. Feldman AM, McNamara D. Myocarditis. N Engl J Med. 2000. 343:1388–1398.

10. Murphy JG, Franz RP. Cooper LT, editor. Endomyocardial biopsy in myocarditis. Myocarditis: From Bench to Bedside. 2003. Totowa, NJ: Humana, Press;371–389.

11. Noutsias M, Pauschinger M, Poller WC, Schultheiss HP, Kühl U. Current insights into the pathogenesis, diagnosis and therapy of inflammatory cardiomyopathy. Heart Fail Monit. 2003. 3:127–135.

12. Park JI, Jeon ES. Mechanical circulatory supports in the treatment of fulminent myocarditis. Korean Circ J. 2005. 35:563–572.